These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6272977

  • 21. Characterization of the microsomal cytochrome P-450 species induced in rat liver by 2-acetylaminofluorene.
    Aström A, Meijer J, DePierre JW.
    Cancer Res; 1983 Jan; 43(1):342-8. PubMed ID: 6291757
    [Abstract] [Full Text] [Related]

  • 22. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
    Shu HP, Bymun EN.
    Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
    [Abstract] [Full Text] [Related]

  • 23. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX, Dalvie DK, Kelly JM, Soglia JR, Frederick KS, Smith EB, Obach RS, Kalgutkar AS.
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [Abstract] [Full Text] [Related]

  • 24. Methylation of catechins and procyanidins by rat and human catechol-O-methyltransferase: metabolite profiling and molecular modeling studies.
    Weinert CH, Wiese S, Rawel HM, Esatbeyoglu T, Winterhalter P, Homann T, Kulling SE.
    Drug Metab Dispos; 2012 Feb; 40(2):353-9. PubMed ID: 22071171
    [Abstract] [Full Text] [Related]

  • 25. Vitamin K as a regulator of benzo(a)pyrene metabolism, mutagenesis, and carcinogenesis. Studies with rat microsomes and tumorigenesis in mice.
    Israels LG, Walls GA, Ollmann DJ, Friesen E, Israels ED.
    J Clin Invest; 1983 May; 71(5):1130-40. PubMed ID: 6304144
    [Abstract] [Full Text] [Related]

  • 26. Multiple reactive metabolites derived from bromobenzene.
    Lau SS, Monks TJ, Gillette JR.
    Drug Metab Dispos; 1984 May; 12(3):291-6. PubMed ID: 6145555
    [Abstract] [Full Text] [Related]

  • 27. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
    Golan MD, Bücker M, Schmassmann HU, Raphael D, Jung R, Bindel U, Brase HO, Tegtmeyer F, Friedberg T, Lorenz J, Stasiecki P, Oesch F.
    Drug Metab Dispos; 1980 May; 8(3):121-6. PubMed ID: 6104571
    [No Abstract] [Full Text] [Related]

  • 28. Benzo(a)pyrene metabolism by rat liver microsomes: effects of adding purified glutathione S-transferases A, B, and C.
    Morgenstern R, Guthenberg C, Mannervik B, DePierre JW, Ernster L.
    Cancer Res; 1982 Oct; 42(10):4215-21. PubMed ID: 6286104
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
    Yao J, Li Y, Chang M, Wu H, Yang X, Goodman JE, Liu X, Liu H, Mesecar AD, Van Breemen RB, Yager JD, Bolton JL.
    Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
    [Abstract] [Full Text] [Related]

  • 31. Catechol metabolites of zeranol and 17β-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase.
    Fleck SC, Hildebrand AA, Pfeiffer E, Metzler M.
    Toxicol Lett; 2012 Apr 05; 210(1):9-14. PubMed ID: 22285433
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
    Zhu BT, Patel UK, Cai MX, Conney AH.
    Drug Metab Dispos; 2000 Sep 05; 28(9):1024-30. PubMed ID: 10950844
    [Abstract] [Full Text] [Related]

  • 34. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM, Oudshoorn MJ, Van Ommen B, Haenen GR, Van Bladeren PJ.
    Chem Res Toxicol; 1996 Dec 05; 9(8):1249-56. PubMed ID: 8951226
    [Abstract] [Full Text] [Related]

  • 35. In vitro metabolism of benzo(a)pyrene by human liver microsomes and lymphocytes.
    Selkirk JK, Croy RG, Whitlock JP, Gelboin HV.
    Cancer Res; 1975 Dec 05; 35(12):3651-5. PubMed ID: 1192426
    [Abstract] [Full Text] [Related]

  • 36. Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection.
    Schultz E, Nissinen E, Kaakkola S.
    Biomed Chromatogr; 1989 Mar 05; 3(2):64-7. PubMed ID: 2736320
    [Abstract] [Full Text] [Related]

  • 37. Microsomal metabolism of 4-(N,N-diacetylamino)benzo[a]pyrene: a potent mutagenic arylamide derived from a carcinogenic polycyclic aromatic hydrocarbon.
    Chou MW, Miller DW, Freeman JP, Fu PP.
    Chem Res Toxicol; 1988 Mar 05; 1(2):115-22. PubMed ID: 2979718
    [Abstract] [Full Text] [Related]

  • 38. Irreversible binding of ethynylestradiol metabolites to protein: lack of methylation by S-adenosyl-methionine.
    Kappus H, Bolt HM.
    Horm Metab Res; 1974 Jul 05; 6(4):333-4. PubMed ID: 4153385
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Radical cations as precursors in the metabolic formation of quinones from benzo[a]pyrene and 6-fluorobenzo[a]pyrene. Fluoro substitution as a probe for one-electron oxidation in aromatic substrates.
    Cavalieri EL, Rogan EG, Cremonesi P, Devanesan PD.
    Biochem Pharmacol; 1988 Jun 01; 37(11):2173-82. PubMed ID: 2837229
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.